Various mechanisms can be involved, including upregulation of inhibitory ligands and non-classical MHC class I molecules HLA-E and HLA-G on the tumour that suppress NK cell cytotoxicity and induce tumour tolerance [27,28,29]. This evidence concerns the gene HLA-E and neoplasm.